FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update

FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update

TORONTO–(BUSINESS WIRE)–
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced its financial results for the third quarter ending September 30, 2020 and provided a corporate update. The filing is available on SEDAR.

Financial and corporate highlights include:

  • Completion of financings for gross proceeds of $19.5 million USD through two registered direct offerings. As of September 30, 2020, cash & non-cash assets are $56.2 million CAD and short & long term liabilities are $13.6 million CAD.
  • Filing an Investigational New Drug Application (“IND”) application with the U.S. Food and Drug Administration (“FDA”) and receiving approval to initiate a Phase 2 clinical trial for the use of our lead compound, ultramicronized-palmitoylethanolamide (or ultramicronized PEA) (“FSD201”), to treat 352 hospitalized COVID-19 patients in a double-blind study. We believe FSD201 to be a safe drug with anti-inflammatory properties which may have the potential to address the over-exuberant inflammatory response characterized by COVID-19 infection that may lead to a cytokine storm and ultimately death. The Company believes it has sufficient cash on hand to complete the study. More information on the clinical trial is available on the U.S. National Library of Medicine Website at: https://clinicaltrials.gov/ct2/show/NCT04619706?term=palmitoylethanolamide&cond=Covid19&draw=2&rank=2. The contents of such website are not incorporated by reference herein.
  • Entry into a definitive settlement agreement with respect to the class action litigation commenced by a plaintiff shareholder in the Ontario Superior Court of Justice in February 2019 relating to the build out of the Company’s facility in Cobourg, Ontario. The Company is obligated to pay $5.5 million CAD in settlement; of which, approximately $4.6 million CAD will be funded from insurance proceeds and $0.9 million CAD will be paid from cash on hand by the Company. The settlement agreement is subject to customary conditions.
  • Entry into a conditional contract to sell non-core real estate asset in Cobourg, Ontario which is expected to close before year end 2020 and is subject to customary conditions.

Three and Nine Months’ Financial Results (All Figures in C$)

For the three and nine months ended September 30, 2020, total operating expenses were $17,486,928 and $32,791,748, respectively, compared to $11,119,296 and $21,474,025 for the comparative periods in the prior year. This represents an increase of $6,367,632 or 57% for the three months ended September 30, 2020 and an increase of $11,317,723 or 53% for the nine months ended September 30, 2020, compared to the equivalent periods in the prior year. The increase for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019 is primarily related to pharmaceutical R&D expense of the Phase 1 safety & tolerability study of FSD201, ongoing Phase 2 clinical study of FSD201 to evaluate treatment of hospitalized COVID-19 patients, higher stock based compensation, higher professional fees, and insurance expense as a result of the Nasdaq listing in January 2020.

For the three and nine months ended September 30, 2020, net loss was $18,034,382 and $36,450,247, respectively, compared to $16,962,007 and $34,949,559 for the three and nine months ended September 30, 2019. This represents an increase of $1,072,375 or 6% for the three months ended September 30, 2020 and an increase of $1,500,688 or 4% for the nine months ended September 30, 2020, compared to the equivalent periods in the prior year. The net loss in the three, and, nine month period ending September 30 2020 includes share based compensation of $6,870,177 and one time charge of $928,541 for the class action settlement.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2-Coronavirus) at this time.

About FSD Pharma

FSD Pharma Inc. is a publicly-traded holding company.

FSD Pharma BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, FSD201, by down-regulating the cytokines to effectuate an anti-inflammatory response.

The Company filed an IND with the FDA on August 28, 2020 and was approved on September 25, 2020 to initiate a phase 2 clinical trial for the use of FSD201 to treat COVID-19, the disease caused by the SARS-CoV-2 virus.

Severe COVID-19 is characterized by an over-exuberant inflammatory response that may lead to a cytokine storm and ultimately death. The Company is focused on developing FSD201 for its anti-inflammatory properties to avoid the cytokine storm associated with acute lung injury in hospitalized COVID-19 patients.

Forward-Looking Statements

Neither the Canadian Securities Exchange nor its regulation services provider accept responsibility for the adequacy or accuracy of this press release.

Certain statements contained in this press release constitute “forward-looking information” and “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws (collectively, “Forward-Looking Information”). Forward-Looking Information includes, but is not limited to, information with respect to FSD Pharma’s strategy, plans or future financial or operating performance, receipt of any FDA approvals, the completion of any trials regarding the use of FSD201 to treat COVID-19, the safety of FSD201 or whether FSD201 may be effective in treating COVID-19, the costs associated with such planned trials and our belief that we have sufficient cash to complete the Phase 2 study, our ability to obtain required funding and the terms and timing thereof, the ultimate development of any FDA approved synthetic compounds, the expected insurance recovery related to the settlement agreement, the completion of the settlement contemplated in the settlement agreement and the timing and closing of the sale of certain non-core real estate assets. The use of words such as “budget”, “intend”, “anticipate”, “believe”, “expect”, “plan”, “forecast”, “future”, “target”, “project”, “capacity”, “could”, “should”, “focus”, “proposed”, “scheduled”, “outlook”, “potential”, “estimate” and other similar words, and similar expressions and statements relating to matters that are not historical facts, or statements that certain events or conditions “may” or “will” occur, are intended to identify Forward-Looking Information and are based on FSD Pharma’s current beliefs or assumptions as to the outcome and timing of such future events. Such beliefs or assumptions necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such Forward‐Looking Information. Certain of these risks and uncertainties are described in the Company’s continuous disclosure filings available under the Company’s SEDAR profile at www.sedar.com and under the Company’s EDGAR profile at www.sec.gov. Forward‐Looking Information is not a guarantee of performance. The Forward-Looking Information contained in this press release is made as of the date hereof, and FSD Pharma is not obligated to update or revise any Forward- Looking Information, whether as a result of new information, future events or otherwise, except as required by law. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on Forward Looking-Information. The foregoing statements expressly qualify any Forward-Looking Information contained herein.

For further information:

Sandy Huard, Head of Communications, FSD Pharma Inc.

[email protected]

(647) 864-7969

Donal Carroll, Chief Financial Officer, FSD Pharma Inc.

[email protected]

Investor Relations

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Logo
Logo

Chemtrade Logistics Income Fund Reports Third Quarter 2020 Results and Timing of CEO Succession

Chemtrade Logistics Income Fund Reports Third Quarter 2020 Results and Timing of CEO Succession

TORONTO–(BUSINESS WIRE)–
Chemtrade Logistics Income Fund (TSX: CHE.UN) today announced results for the three months and nine months ended September 30, 2020. The financial statements and MD&A will be available on Chemtrade’s website at www.chemtradelogistics.com and on SEDAR at www.sedar.com.

Chemtrade President and Chief Executive Officer, Mark Davis, said, “The COVID-19 pandemic continued to adversely affect the demand for some, but not all of our products. Demand for our water business was unaffected resulting in another strong quarterly performance. Once the economic effect of the pandemic eases we expect to see demand for the adversely affected products increase. Our highest priority continues to be the health and safety of our employees. I would like to thank them for their outstanding performance during these difficult times and for keeping our customers reliably supplied.”

Revenue for the third quarter was $345.9 million, a decrease of $49.8 million from the third quarter of 2019. The decrease in revenue is primarily due to lower selling prices and sales volumes for hydrochloric acid (“HCl”) and caustic soda in the Electrochemicals (“EC”) segment, and lower sales volumes of regen and merchant sulphuric acid in the Sulphur Products and Performance Chemicals (“SPPC”) segment.

Net loss for the third quarter of 2020 was $48.3 million, compared with a net loss of $0.2 million in 2019. The increase is primarily due to lower Adjusted EBITDA(1) (“EBITDA”), higher net finance costs due to a higher loss from the change in the fair value of convertible unsecured subordinated debentures (“Debentures”), transaction costs related to the issuance of Debentures in the third quarter of 2020 partially offset by higher income tax recovery compared with the same period of 2019.

EBITDA for the third quarter of 2020 was $64.7 million compared with $90.0 million in the third quarter of 2019. EBITDA during the third quarter of 2020 was negatively affected by lower selling prices for caustic soda and HCl and by reduced demand for HCl. EBITDA was also negatively affected by reduced demand for acid products in the SPPC segment.

Cash flows from operating activities were $90.9 million compared with $80.5 million during the third quarter of 2019. Adjusted cash flow from operating activities(1) was $29.4 million compared with $56.8 million generated during the third quarter of 2019.

Distributable Cash after maintenance capital expenditures(1) for the third quarter of 2020 was $12.1 million or $0.13 per unit compared with $37.1 million or $0.40 per unit in 2019.

For the nine months ended September 30, 2020, Distributable Cash after maintenance capital expenditures was $82.0 million, or $0.89 per unit compared with $80.6 million, or $0.87 per unit in 2019. Results for the first nine months of 2019 included a litigation reserve (“Litigation Reserve”) of $40.0 million. Excluding the Litigation Reserve, Distributable Cash after maintenance capital expenditures was $120.6 million, or $1.30 per unit for the first nine months of 2019.

Revenue for the first nine months of 2020 was $1.1 billion (2019: $1.2 billion). EBITDA was $221.1 million (2019: $225.3 million). Adjusted cash flow from operating activities was $122.4 million (2019: $126.5 million).

In the third quarter of 2020, SPPC generated revenue of $105.4 million compared with $127.8 million in 2019. The decrease in revenue in the third quarter of 2020 was primarily due to lower sales volumes for regen and merchant sulphuric acid and other SPPC products as a result of the COVID-19 pandemic. EBITDA for the third quarter of 2020 was $31.0 million, which was $12.6 million lower than the same quarter of 2019.

The Water Products and Specialty Chemicals (“WSSC”) segment reported third quarter revenue of $119.8 million compared with $122.4 million in 2019. The slight decrease is due to lower sales volumes of water solutions products and lower sales volumes of specialty chemical products, partially offset by higher selling prices of water solutions products. EBITDA improved to $29.2 million from the $24.3 million generated in 2019. The improvement was due to higher margins for water products, which benefitted from higher selling prices and lower raw material costs.

The EC segment reported revenue of $120.7 million for the third quarter of 2020, which was $24.7 million lower than the same period of 2019. The lower revenue in the third quarter of 2020 was primarily due to lower sales volumes for HCl and caustic soda, a decrease of 30% in selling prices for HCl, and a decrease of 11% in selling prices for caustic soda. This was partially offset by a 4% increase in selling prices for chlorine. EBITDA of $24.6 million for the third quarter of 2020 was $18.2 million lower than the same period of 2019. This was primarily due to lower selling prices for both caustic soda and HCl, as well as the effect of operating the North Vancouver facility at reduced rates. The production rate was constrained by reduced demand for HCl. In the third quarter, netbacks, i.e., selling prices less freight, for HCl were 43% lower compared with the same period of 2019.

Corporate costs during the third quarter of 2020 were $20.2 million, compared with $20.8 million in the third quarter of 2019. The lower costs were primarily due to lower incentive compensation accruals.

During the third quarter Chemtrade commenced the process of redeeming the outstanding 5.25% Debentures that were set to mature in 2021 (the “2021 Debentures”). The redemption was partially funded by a public offering of $86.3 million principal amount of Debentures, at a price of $1,000 per Debenture, with an interest rate of 8.50% per annum. Those funds, plus availability under Chemtrade’s credit agreement, were used during and after the quarter’s end to complete the redemption of the 2021 Debentures at their face amount plus accrued interest for a total of $128.3 million.

Commenting on Chemtrade’s future outlook, Mr. Davis said, “Demand for certain of our products will continue to be adversely affected as long as the COVID-19 pandemic restricts economic activity and travel. When the economic effect of the pandemic recedes we expect to see increasing demand for our products and higher earnings. Based on the novelty and severity of COVID-19’s effect on 2020, we expect that Chemtrade’s earnings will be higher in future years then they will be in 2020. With respect to the fourth quarter in particular, there will be two major plant turnarounds which will affect our fourth quarter results – the biennial maintenance turnaround of our North Vancouver chlor-alkali plant, which was moved from earlier in the year to the fourth quarter, and the turnaround of one of our regen plants which is tied to a once every five-year major maintenance turnaround at this plant’s refinery customer. While we have not reinstated our Guidance, the Financial Outlook section of the third quarter MD&A has additional information on our outlook.”

Mark Davis to retire February 28, 2021; Scott Rook to assume CEO role March 1, 2021

As announced in August, Mark Davis is retiring as CEO after 20 years’ service. The date for the transition has now been set, with Mr. Davis’ retirement effective February 28, 2021 and Scott Rook assuming the role effective March 1, 2021. On the same date, Mr. Rook will be appointed to the Board of Trustees as Mr. Davis steps down from the Board.

Distributions & Distribution Reinvestment Plan

Distributions declared in the third quarter totalled $0.15 per unit, comprised of monthly Distributions of $0.05 per unit. In July 2020, Chemtrade established a Distribution Reinvestment Plan that became available with the July distribution, which was payable at the end of August 2020. The plan provides a way for unitholders to accumulate additional Chemtrade units without fees and currently includes a 3% bonus distribution.

About Chemtrade

Chemtrade operates a diversified business providing industrial chemicals and services to customers in North America and around the world. Chemtrade is one of North America’s largest suppliers of sulphuric acid, regen acid processing services, inorganic coagulants for water treatment, sodium chlorate, sodium nitrite, sodium hydrosulphite and phosphorus pentasulphide. Chemtrade is a leading regional supplier of sulphur, chlor-alkali products, liquid sulphur dioxide, potassium chloride, and zinc oxide. Additionally, Chemtrade provides industrial services such as processing by-products and waste streams.

(1) Non–IFRS Measures

EBITDA and Adjusted EBITDA –

Management defines EBITDA as net earnings before any deduction for net finance costs, income taxes, depreciation and amortization. Adjusted EBITDA also excludes other non-cash charges such as impairment, change in environmental liability, gains and losses on the disposal and write-down of property, plant and equipment (“PPE”), and unrealized foreign exchange gains and losses. EBITDA and Adjusted EBITDA are metrics used by many investors and analysts to compare organizations on the basis of ability to generate cash from operations. Management considers Adjusted EBITDA (as defined) to be an indirect measure of operating cash flow, which is a significant indicator of the success of any business. Adjusted EBITDA is not intended to be representative of cash flow from operations or results of operations determined in accordance with IFRS or cash available for distribution.

EBITDA and Adjusted EBITDA are not recognized measures under IFRS. Chemtrade’s method of calculating EBITDA and Adjusted EBITDA may differ from methods used by other income trusts or companies, and accordingly may not be comparable to similar measures presented by other organizations.

A reconciliation of net earnings to EBITDA and Adjusted EBITDA is provided below:

Three months ended September 30

Nine months ended September 30

($’000)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

Net loss

$

(48,318

)

$

(163

)

$

(141,694

)

$

(87,057

)

Add:

 

 

Depreciation and amortization

 

64,640

 

 

65,380

 

 

197,566

 

 

197,036

 

Net finance costs

 

46,121

 

 

22,675

 

 

116,279

 

 

75,997

 

Income tax recovery

 

(17,627

)

 

(8,825

)

 

(32,626

)

 

(28,701

)

EBITDA

 

44,816

 

 

79,067

 

 

139,525

 

 

157,275

 

Add:

 

 

Impairment of goodwill

 

 

 

 

 

56,000

 

 

65,600

 

Change in environmental liability

 

 

 

 

 

3,743

 

 

 

Loss on disposal and write-down of PPE

 

19,829

 

 

9,917

 

 

19,360

 

 

10,522

 

Unrealized foreign exchange loss (gain)

 

5

 

 

1,046

 

 

2,430

 

 

(8,127

)

Adjusted EBITDA

$

64,650

 

$

90,030

 

$

221,058

 

$

225,270

 

 

 

SPPC –

 

 

 

Three months ended September 30

Nine months ended September 30

($’000)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

Revenue

$

105,351

 

$

127,798

 

$

322,333

 

$

385,318

 

Gross (loss) profit

 

(8,298

)

 

11,086

 

 

15,657

 

 

45,894

 

 

 

Adjusted EBITDA

 

31,041

 

 

43,689

 

 

97,287

 

 

126,502

 

Loss on disposal and write-

 

 

 

down of PPE

 

(18,949

)

 

(9,221

)

 

(18,932

)

 

(9,973

)

EBITDA

$

12,092

 

$

34,468

 

$

78,355

 

$

116,529

 

 

 

 WSSC –

 

 

Three months ended September 30

Nine months ended September 30

($’000)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

Revenue

$

119,789

 

$

122,432

 

$

346,583

 

$

343,330

 

Gross profit (loss)

 

19,195

 

 

12,836

 

 

(6,220

)

 

(34,457

)

 

 

Adjusted EBITDA

 

29,199

 

 

24,335

 

 

82,145

 

 

63,261

 

Impairment of goodwill

 

 

 

 

 

(56,000

)

 

(65,600

)

Change in environmental liability

 

 

 

 

 

(3,743

)

 

 

Loss on disposal and write-down

 

of PPE

 

(894

)

 

(1,661

)

 

(437

)

 

(1,657

)

EBITDA

$

28,305

 

$

22,674

 

$

21,965

 

$

(3,996

)

 

 EC –

Three months ended September 30

Nine months ended September 30

($’000)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

North American sales volumes:

 

 

Sodium chlorate sales volume (000’s MT)

 

87

 

 

98

 

 

283

 

 

294

 

Chlor-alkali sales volume (000’s MECU)

 

42

 

 

49

 

 

111

 

 

140

 

 

 

Revenue

$

120,710

 

$

145,423

 

$

391,369

 

$

448,992

 

Gross (loss) profit

 

(3,508

)

 

17,495

 

 

9,518

 

 

62,133

 

 

 

Adjusted EBITDA

 

24,594

 

 

42,804

 

 

93,561

 

 

137,298

 

Gain (loss) on disposal and

 

write-down of PPE

 

14

 

 

(178

)

 

9

 

 

873

 

EBITDA

$

24,608

 

$

42,626

 

$

93,570

 

$

138,171

 

 

Cash Flow –

The following table is derived from, and should be read in conjunction with the condensed consolidated interim statements of cash flows. Management believes this supplementary disclosure provides useful additional information related to the cash flows of Chemtrade including the amount of cash available for distribution to Unitholders, repayment of debt and other investing activities. Certain sub-totals presented within the cash flows table below, such as “Adjusted cash flows from operating activities”, “Distributable Cash after maintenance capital expenditures” and “Distributable Cash after all capital expenditures”, are not defined terms under IFRS. These sub-totals are used by Management as measures of internal performance and as a supplement to the condensed consolidated interim statements of cash flows. Investors are cautioned that these measures should not be construed as an alternative to using net earnings as a measure of profitability or as an alternative to the IFRS condensed consolidated interim statements of cash flows. Further, Chemtrade’s method of calculating each measure may not be comparable to calculations used by other income trusts or companies bearing the same description.

Three months ended September 30

Nine months ended September 30

($’000)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

Cash flows from operating activities

$

90,866

 

$

80,462

 

$

188,763

 

$

78,818

 

Add (Less):

 

 

Lease payments net of sub-lease receipts

 

(14,256

)

 

(14,131

)

 

(42,418

)

 

(42,616

)

Changes in non-cash working capital and other items

 

(47,168

)

 

(9,524

)

 

(23,910

)

 

90,291

 

Adjusted cash flows from operating activities

 

29,442

 

 

56,807

 

 

122,435

 

 

126,493

 

Less:

 

 

Maintenance capital expenditures

 

17,346

 

 

19,668

 

 

40,444

 

 

45,872

 

Distributable cash after maintenance capital

 

expenditures

 

12,096

 

 

37,139

 

 

81,991

 

 

80,621

 

Less:

 

 

Non-maintenance capital expenditures

 

743

 

 

4,631

 

 

2,283

 

 

9,833

 

Distributable cash after all capital expenditures

$

11,353

 

$

32,508

 

$

79,708

 

$

70,788

Caution Regarding Forward-Looking Statements

Certain statements contained in this news release constitute forward-looking statements within the meaning of certain securities laws, including the Securities Act (Ontario). Forward-looking statements can be generally identified by the use of words such as “anticipate”, “continue”, “estimate”, “expect”, “expected”, “intend”, “may”, “will”, “project”, “plan”, “should”, “believe” and similar expressions. Specifically, forward-looking statements in this news release include statements respecting certain future expectations about: the expected adverse effects on demand for certain products during the pandemic and expected increased demand for certain products and higher earnings once the pandemic’s economic effect eases; the expectation that future earnings will be higher than 2020 earnings; and the effects on fourth quarter results of plant turnarounds; and the timing of and transition of the CEO. Forward-looking statements in this news release describe the expectations of the Fund and its subsidiaries as of the date hereof. These statements are based on assumptions and involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements for a variety of reasons, including without limitation the risks and uncertainties detailed under the “RISK FACTORS” section of the Fund’s latest Annual Information Form and the “RISKS AND UNCERTAINTIES” section of the Fund’s most recent Management’s Discussion & Analysis.

Although the Fund believes the expectations reflected in these forward-looking statements and the assumptions upon which they are based are reasonable, no assurance can be given that actual results will be consistent with such forward-looking statements, and they should not be unduly relied upon. With respect to the forward-looking statements contained in this news release, the Fund has made assumptions regarding: there being no significant disruptions affecting the operations of the Fund and its subsidiaries, whether due to labour disruptions, supply disruptions, power disruptions, transportation disruptions, damage to equipment or otherwise; the ability of the Fund to obtain products, raw materials, equipment, transportation, services and supplies in a timely manner to carry out its activities and at prices consistent with current levels or in line with the Fund’s expectations; the timely receipt of required regulatory approvals; the cost of regulatory and environmental compliance being consistent with current levels or in line with the Fund’s expectations; the ability of the Fund to successfully access tax losses and tax attributes; the ability of the Fund to obtain financing on acceptable terms; currency, exchange and interest rates being consistent with current levels or in line with the Fund’s expectations; and global economic performance.

Except as required by law, the Fund does not undertake to update or revise any forward-looking statements, whether as a result of new information, future events or for any other reason. The forward-looking statements contained herein are expressly qualified in their entirety by this cautionary statement.

Further information can be found in the disclosure documents filed by Chemtrade Logistics Income Fund with the securities regulatory authorities, available at www.sedar.com.

A conference call to review the third quarter 2020 results will be webcast live on Friday, November 13, 2020 at 10:00 a.m. ET. To access the webcast click here.

Mark Davis

President and CEO

Tel: (416) 496-4176

Rohit Bhardwaj

Vice-President, Finance and CFO

Tel: (416) 496-4177

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Chemicals/Plastics Manufacturing

MEDIA:

Logo
Logo

Carvana to Present at Upcoming Investor Conferences

Carvana to Present at Upcoming Investor Conferences

PHOENIX–(BUSINESS WIRE)–
Carvana Co. (NYSE: CVNA), a leading e-commerce platform for buying and selling used cars, today announced that senior management will present to the investment community and host meetings at the following virtual conferences:

Stephens Annual Investment Conference 2020

Presentation Date: Thursday, November 19, 2020, 10:00 a.m. ET*

Credit Suisse 24th Annual Technology Conference

Presentation Date: Thursday, December 3, 2020, 10:40 a.m. ET*

*A webcast of the presentation will be accessible on the investor relations section of the Carvana website (https://investors.carvana.com/). An archived replay of the webcast will be available following the live presentation.

About Carvana (NYSE: CVNA)

Founded in 2012 and based in Phoenix, Carvana’s (NYSE: CVNA) mission is to change the way people buy cars. By removing the traditional dealership infrastructure and replacing it with technology and exceptional customer service, Carvana offers consumers an intuitive and convenient online car buying and financing platform. Carvana.com enables consumers to quickly and easily shop more than 20,000 vehicles, finance, trade-in or sell their current vehicle to Carvana, sign contracts, and schedule as-soon-as-next-day delivery or pickup at one of Carvana’s patented, automated Car Vending Machines.

For further information on Carvana, please visit www.carvana.com, or connect with us on Facebook, Instagram or Twitter.

Investor Relations:

Carvana

Mike Levin

[email protected]

or

Media Contact:

Carvana

Amy O’Hara

[email protected]

KEYWORDS: United States North America Arizona

INDUSTRY KEYWORDS: Automotive Online Retail Technology Professional Services Specialty Public Relations/Investor Relations Communications General Automotive Retail Internet Finance

MEDIA:

Logo
Logo

nVent Introduces RackChiller CDU800 Coolant Distribution Unit at SC20

nVent Introduces RackChiller CDU800 Coolant Distribution Unit at SC20

Next Generation High-Density Liquid Cooling Solution for Data Centers

LONDON–(BUSINESS WIRE)–
nVent Electric plc (NYSE:NVT) (“nVent”), a global leader in electrical connection and protection solutions, will introduce its new nVent HOFFMAN RackChiller CDU800 Coolant Distribution Unit (CDU) during the virtual SC20 conference, November 17-19, 2020. The RackChiller CDU expands nVent’s data center cooling portfolio to support high-density liquid cooling for high performance computing (HPC), hyperscale, enterprise and edge applications.

“New generation chips are generating more heat which will eclipse the capacity of air cooling,” says Aravind Padmanabhan, nVent Executive Vice President and Chief Technology Officer. “Additionally the rising demand for IT processing power to support services like video conferencing, e-commerce transactions, autonomous driving and 5G means solution engineers must think differently to address these cooling challenges.”

nVent has manufactured data center high-density liquid cooling solutions for more than a decade. The introduction of RackChiller CDU marks the first time one of its high-density liquid cooling solutions will be available as a standard product.

“Up until now, all of our high-density liquid cooling solutions have been application-specific and custom-built, which can be time-consuming and costly,” says Joe Ruzynski, President of the nVent Enclosures segment. “We created the RackChiller CDU to serve the emerging data center high-density liquid cooling market, where our customers need a flexible solution they can implement quickly across a range of different applications.”

The RackChiller CDU consistently delivers liquid coolant to maximize cooling efficiency, while taking up very little data center floor space, and removes heat from sensitive equipment through a constant cycle of pumping and heat exchange. It features a powerful cooling capacity of 800kW and a compact footprint of 35 (w) x 47 (d) inches (800 x 1200-mm).

nVent will present the RackChiller CDU during the virtual SC20 conference and is currently accepting pre-order reservations for delivery in early 2021. Those interested in learning more can register for SC20 and join nVent in its virtual booth or request a virtual introduction after SC20. (Click here for SC20 media registration.)

Technical Specifications

The RackChiller CDU provides 800kW of liquid cooling capacity at 4K approach temperature and delivers high-performance liquid flow, pressure delivery and heat dissipation within a standard IT rack footprint. The CDU is an ideal high-density liquid coolant distribution solution for close-coupled and direct-to-chip cooling applications. The RackChiller CDU800 is well-matched for high performance computing (HPC) and enterprise, hyperscale, co-location, multi-tenant data center liquid cooling solutions.

The RackChiller CDU800 is designed for reliability, availability and serviceability. The platform is designed with N+N redundant pumps that provide up to 850 liters per minute secondary flow and 46 psi (3.2 bar) differential pressure. The CDU includes a smart control system that continuously monitors over 35 integrated sensors. This combination, coupled with low approach temperature throughout the operating range, eliminates the need for costly chiller support and enables ASHRAE W4 warm water liquid cooling of high-power IT systems. The pumps, sensors and filtration system are serviceable without incurring downtime or performance impact during operation.

About nVent

nVent is a leading global provider of electrical connection and protection solutions. We believe our inventive electrical solutions enable safer systems and ensure a more secure world. We design, manufacture, market, install and service high performance products and solutions that connect and protect some of the world’s most sensitive equipment, buildings and critical processes. We offer a comprehensive range of enclosures, electrical connections and fastening and thermal management solutions across industry-leading brands that are recognized globally for quality, reliability and innovation. Our principal office is in London and our management office in the United States is in Minneapolis. Our robust portfolio of leading electrical product brands dates back more than 100 years and includes nVent CADDY, ERICO, HOFFMAN, RAYCHEM, SCHROFF and TRACER.

nVent, CADDY, ERICO, HOFFMAN, RAYCHEM, SCHROFF and TRACER are trademarks owned or licensed by nVent Services GmbH or its affiliates.

Beth Morrill

[email protected]

+1 919-352-6259

KEYWORDS: Europe United States United Kingdom North America Minnesota

INDUSTRY KEYWORDS: Hardware Semiconductor Electronic Design Automation Data Management Energy Manufacturing Technology Audio/Video Other Manufacturing Other Technology Telecommunications Networks Other Energy VoIP Internet Engineering

MEDIA:

Williams-Sonoma, Inc. announces release date for third quarter 2020 results: Thursday, November 19, 2020

Williams-Sonoma, Inc. announces release date for third quarter 2020 results: Thursday, November 19, 2020

SAN FRANCISCO–(BUSINESS WIRE)–
Williams-Sonoma, Inc. (NYSE: WSM) announced today that it will release its third quarter 2020 results on Thursday, November 19, 2020 after the market close. Following the release via the wire services, the Company will host a conference call beginning at 5:00 PM Eastern Time, which can be accessed at http://ir.williams-sonomainc.com/events. Following the call, a replay of the webcast will be available at http://ir.williams-sonomainc.com/events beginning at 6:15 PM Eastern Time on Thursday, November 19, 2020.

Williams-Sonoma, Inc. is a specialty retailer of high-quality, sustainable products for the home. These products, representing distinct merchandise strategies — Williams Sonoma, Pottery Barn, Pottery Barn Kids, West Elm, Pottery Barn Teen, Williams Sonoma Home, Rejuvenation, and Mark and Graham — are marketed through e-commerce websites, direct-mail catalogs and retail stores. These brands are also part of The Key Rewards, our free-to-join loyalty program that offers members exclusive benefits across the Williams-Sonoma family of brands. We operate in the U.S., Puerto Rico, Canada, Australia and the United Kingdom, offer international shipping to customers worldwide, and have unaffiliated franchisees that operate stores in the Middle East, the Philippines, Mexico and South Korea, as well as e-commerce websites in certain locations.

WILLIAMS-SONOMA, INC.

Julie Whalen

EVP, Chief Financial Officer

(415) 616-8524

-or-

Elise Wang

VP, Investor Relations and Corp PR

(415) 616-8571

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Retail Home Goods Specialty Luxury

MEDIA:

Sunworks Reports on Special Meeting of Stockholders

Merger Proposal with Peck Company Fails to Win Stockholder Approval

ROSEVILLE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — Sunworks, Inc. (Nasdaq: SUNW), a provider of solar power solutions for agriculture, commercial and industrial (ACI), public works and residential markets, today announced that the proposed merger with the Peck Company Holdings, Inc. (“Peck Company”) failed to secure stockholder approval. Sunworks had established October 9, 2020 as the record date for determining stockholders eligible to vote at the special meeting of stockholders and as of that record date, there were 16,628,992 shares of common stock outstanding and entitled to vote. At the special meeting of stockholders on November 12, 2020, only 4,362,575 votes were cast, or 26% of the total outstanding shares. This total fell short of the quorum required to vote on the proposed merger with the Peck Company. Quorum requires the presence, virtually or represented by proxy, of the holders of a majority of the voting power of the stock issued, outstanding and entitled to vote as of the record date. Therefore, the special meeting of stockholders was concluded and the merger was not approved. Following the special meeting of stockholders, pursuant to the terms of the merger agreement with the Peck Company, Sunworks notified the Peck Company of its decision to terminate the merger agreement.

Chuck Cargile, Sunworks Chairman of the Board, said, “We are disappointed that the proposed merger with the Peck Company failed to gain approval from our stockholders. We believed that this merger would have been the best long-term option for Sunworks and would have provided the best outcome for stockholders. We will continue to have strategic discussions with the Peck leadership team to determine if there are other ways for us to work together to benefit from the many synergies identified in this planned business combination.”

About Sunworks, Inc.

Sunworks, Inc. (NASDAQ:SUNW) is a premier provider of high performance solar power systems. Sunworks is committed to quality business practices that exceed industry standards and uphold its ideals of ethics and safety. Sunworks continues to grow its presence, expanding nationally with regional and local offices. The Company strives to consistently deliver high quality, performance-oriented solutions for customers in a wide range of industries including agricultural, commercial and industrial, state and federal, public works, and residential. Sunworks’ diverse, seasoned workforce includes veterans who bring a sense of pride, discipline, and professionalism to their interaction with customers. Sunworks is a member of the Solar Energy Industries Association (SEIA) and is a proud advocate for the advancement of solar power. For more information, visit www.sunworksusa.com.

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “will,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the Company’s future business relationship with the Peck Company, future sales, revenue, gross profit, gross margin, operating expenses, operating income, net income, cash balance and cash from operating activities. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These risks include, but are not limited to, risks and uncertainties associated with: an inability to take advantage of synergies identified with the Peck Company, the impact of economic, competitive, regulatory, environmental and other factors affecting the Company and its operations, markets and products; the impact of COVID-19 and the related federal, state and local restrictions on the Company’s operations and workforce, the impact of COVID-19 and such restrictions on our customers, and the impact of COVID-19 on the Company’s supply chain and availability of shipping and distribution; the prospects for sales, lower revenues, failure to earn profit, higher costs than expected, potential operating losses, ownership dilution, inability to repay debt, and the inability to complete projects within anticipated timeframes and costs; the impact of tariffs imposed by governmental bodies; the impact of national and local economies generally; the Company’s ability to access governmental assisted financing; and other factors detailed in reports filed by the Company. You should also review the risks described in “Risk Factors” in Part I, Item 1A of Sunworks, Inc.’s Annual Report on Form 10-K and in the other reports and documents Sunworks files with the Securities and Exchange Commission from time to time.

Any forward-looking statement made by us in this press release is based only on information currently available to us and reflects only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Investor Relations Contact:

Rob Fink
FNK IR
646.809.4048
[email protected]

Sysco Eliminates Minimum Delivery Requirements and Offers Value-Added Services to Support Restaurant Industry

Restaurants Rising campaign makes it easier for restaurants to succeed and strengthen their business for the future

HOUSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY), the leading global foodservice distribution company, announced today it will eliminate minimum delivery size requirements for customers’ regularly scheduled delivery days as part of the company’s Restaurants Rising campaign. This change is effective on Nov. 16 for all U.S. Broadline, FreshPoint, Buckhead Meat and Newport Meat customers.

Removing minimum delivery requirements is yet another way Sysco is leading the industry in supporting the success of restaurants, providing operators significant added flexibility in managing their business and making it easier to get what they need, when they need it. This change, while applicable to both large and small customers, is especially helpful to independent restaurant operators planning for potential changes in demand and COVID-19 restrictions during the winter months ahead.

“No other distributor is doing more than Sysco to help the restaurant industry succeed,” said Kevin Hourican, Sysco’s president and chief executive officer. “Eliminating minimum delivery requirements is our latest offering to show our customers that Sysco is on a mission to make it easier to do business with us. Combined with our value-added services and world-class sales team, we are helping restaurants – especially smaller, independent businesses — stay in business, better run their business, and evolve their business to drive increased traffic, now and in a post-pandemic world.”

In addition to the elimination of order minimums, Sysco’s value-added services and strategic partnership discounts are available for current and new customers, including:

  • FREE Restaurant Marketing Tools. Restaurants need to promote their business more than ever before. Our team can produce marketing solutions such as banners and posters that can be printed locally.
  • DISCOUNTS
    on
    s
    olutions
    and
    s
    ervices
    customers
    need right now. Sysco’s partners offer special discounts for important services restaurant operators need, such as delivery, mobile ordering and menu services.
  • FREE
    Sysco

    Foodie Solutions

    . Sysco has the expertise to help operators resolve business issues and generate new revenues. Sysco’s Foodie Solutions Toolkits offer a curated collection of the best industry practices, easy-to-use templates and exclusive, chef-tested products.
  • EASY Credit Card Payment
    . This option provides convenience for both existing and new customers.
  • FAST
    Onboarding for new customers. New customers can onboard in less than 24 hours and begin to benefit from the powerful suite of services, tools and solutions Sysco offers.

For more information, current and prospective customers can contact their Sysco Sales Consultant or visit Sysco.com/rising to get started.


About Sysco


Sysco is the global leader in selling, marketing and distributing food products to restaurants, healthcare and educational facilities, lodging establishments and other customers who prepare meals away from home. Its family of products also includes equipment and supplies for the foodservice and hospitality industries. With more than 57,000 associates, the company operates 326 distribution facilities worldwide and serves more than 625,000 customer locations. For fiscal 2020 that ended June 27, 2020, the company generated sales of more than $52 billion. Information about our CSR program, including Sysco’s 2019 Corporate Social Responsibility Report, can be found at www.sysco.com/csr2020report.

For more information, visit www.sysco.com or connect with Sysco on Facebook at www.facebook.com/SyscoCorporation or Twitter at https://twitter.com/Sysco. For important news and information regarding Sysco, visit the Investor Relations section of the company’s Internet home page at investors.sysco.com, which Sysco plans to use as a primary channel for publishing key information to its investors, some of which may contain material and previously non-public information. Investors should also follow us at www.twitter.com/SyscoStock and download the Sysco IR App, available on the iTunes App Store and the Google Play Market. In addition, investors should continue to review our news releases and filings with the SEC. It is possible that the information we disclose through any of these channels of distribution could be deemed to be material information. 

For more information contact:

Shannon Mutschler
Media Contact
[email protected]
T 281-584-4059

A video accompanying this release is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/ab2d3b9c-29b2-4bcb-a4ff-9d068cf4378b

Schultze Special Purpose Acquisition Corp. and Clever Leaves International Inc. to Participate in SPACInsider Webinar on November 16 at 1:00 p.m. ET

Former U.S. Senate Majority Leader, Tom Daschle Will Also Discuss Cannabis Regulation and Legislation

RYE BROOK, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) — Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves”) today announced that the two companies will participate in a webinar hosted by SPACInsider on November 16, 2020 at 1:00 p.m. ET. Principals of Clever Leaves and SAMA will discuss recent updates to their pending transaction as highlighted below. Clever Leaves Special Advisor and Former Senate Majority Leader, Tom Daschle, will also be participating in the webinar to discuss the potential changing U.S. regulatory landscape. Gavin O’Reilly, who heads Cowen and Company’s cannabis investment banking practice, will help moderate the discussion.

The webinar for this event can be accessed at: https://zoom.us/webinar/register/9716002138660/WN_tAJgR_sJSPaCnmZLHrmWTA

Participants in the webinar will include:

  • Kyle Detwiler: CEO, Clever Leaves
  • Andres Fajardo: President, Clever Leaves
  • Senator Tom Daschle: Clever Leaves Special Advisor, Former U.S. Senate Majority Leader
  • George Schultze: Chairman and CEO, Schultze Special Purpose Acquisition Corp.
  • Gary Julien: EVP and Director, Schultze Special Purpose Acquisition Corp.
  • Gavin O’Reilly: Managing Director, Cowen and Company

On November 9, 2020 the two companies announced that they amended their definitive agreement (the “Business Combination Agreement”), which was entered into on July 25, 2020, pursuant to which a newly formed holding company, Clever Leaves Holdings Inc. (“Holdco”), will acquire SAMA and Clever Leaves (the “Business Combination”) and is anticipated to become a NASDAQ-listed public company trading under the ticker symbol “CLVR”.

Under the amended terms, the initial expected enterprise value has been reduced to $206 million from $255 million and the minimum cash condition for SAMA has been reduced to $26 million from $60 million. Additionally, the cash consideration payable to certain Clever Leaves’ shareholders at closing has been amended, thereby increasing the equity rollover consideration of the transaction to approximately 97% while Schultze Special Purpose Acquisition Sponsor, LLC agreed to restructure its’ equity ownership to better align with the capital retained at closing. In connection with these revised terms, institutional investors have committed over $10 million through a private placement to be funded at closing of the Business Combination. Additionally, select SAMA stockholders have agreed not to redeem their shares held thereby providing a path to over $16 million of additional committed capital1 and thus having adequate capital to consummate the transaction. When including SAMA’s cash in trust, the parties expect to have over $80 million of cash on its balance sheet following closing.

The amendments to the Business Combination Agreement have been unanimously approved by the Boards of Directors of both SAMA and Clever Leaves and the transaction remains on track to close in the fourth quarter of 2020, subject to the Registration Statement being declared effective by the SEC, in addition to other regulatory and shareholder approvals, as well as customary closing conditions.

Canaccord Genuity and EarlyBirdCapital are serving as financial advisors to SAMA, with Greenberg Traurig, LLP, Stikeman Elliott and Posse Herrera Ruiz serving as legal advisors. Cowen is serving as financial advisor to Clever Leaves, with Freshfields Bruckhaus Deringer US LLP, Dentons Canada LLP, and Brigard & Urrutia Abogados SAS serving as legal advisors.

About Schultze Special Purpose Acquisition Corp.

Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. SAMA’s sponsor is an affiliate of Schultze Asset Management, LP, an alternative investment management firm founded in 1998 that focuses on distressed, special situation and event-driven securities and has invested over $3.2 billion since inception with a notable track-record through its active investment strategy. SAMA itself is backed by an experienced team of operators and investors with a successful track-record of creating material value in public and private companies.

About Clever Leaves

Clever Leaves is a multi-national cannabis company with a mission to operate in compliance with federal and state laws and with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabinoid business. With operations and investments in Canada, Colombia, Germany, Portugal, and the United States, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry’s leading global cannabinoid companies recognized for its principles, people, and performance while fostering a healthier global community.

About
SPACInsider

SPACInsider is a trusted intelligence and analysis provider specializing in the Special Purpose Acquisition Corporation (SPAC) asset class. SPACInsider’s mission is to be the best-in-class source for SPAC information benefiting investors, SPAC teams, bankers and service providers. The company provides comprehensive data covering the SPAC transaction universe, along with detailed analysis and coverage of IPO and acquisition events. SPACInsider is led by Kristi Marvin, a career investment banker with over 15 years of experience in the capital markets, who began working on SPACs in 2005.

Additional Information and Where to Find It

SAMA, Clever Leaves and Holdco urge investors, stockholders and other interested persons to read the Registration Statement, including the proxy statement/prospectus, as well as other documents filed with the SEC, because these documents will contain important information about the Business Combination. Following the Registration Statement having been declared effective by the SEC, a definitive proxy statement/prospectus will be mailed to stockholders of SAMA as of a record date to be established for voting on the Business Combination. SAMA’s stockholders will also be able to obtain a copy of such documents, without charge, by directing a request to: Schultze Special Purpose Acquisition Corp, 800 Westchester Avenue, Suite 632, Rye Brook, New York 10573; e-mail: [email protected]. These documents, once available, can also be obtained, without charge, at the SEC’s web site (http://www.sec.gov).

Participants in Solicitation

SAMA, Clever Leaves, Holdco and their respective directors, executive officers and other members of their management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of SAMA stockholders in connection with the Business Combination. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to SAMA’s stockholders in connection with the Business Combination is set forth in the preliminary proxy statement/prospectus contained in the Registration Statement, and will also be included in the definitive proxy statement/prospectus for the Business Combination when available. Information concerning the interests of SAMA’s and Clever Leaves’ participants in the solicitation, which may, in some cases, be different than those of SAMA’s and Clever Leaves’ equity holders generally, is also set forth in the proxy statement/prospectus contained in the Registration Statement, and will also be included in the definitive proxy statement/prospectus for the Business Combination when available.

Forward Looking Statements

This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts and may be identified by the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions). Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Factors that may cause such differences include, without limitation, SAMA’s and Clever Leaves’ inability to complete the transactions contemplated by the Business Combination; matters discovered by the parties as they complete their respective due diligence investigation of the other; the inability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, the amount of cash available following any redemptions by SAMA stockholders and the ability to close the private placement with certain institutional investors; the ability to meet NASDAQ’s listing standards following the consummation of the Business Combination; costs related to the Business Combination; expectations with respect to future operating and financial performance and growth, including when Clever Leaves or Holdco will become cash flow positive; the timing of the completion of the Business Combination; Clever Leaves’ ability to execute its business plans and strategy and to receive regulatory approvals; potential litigation involving the parties; global economic conditions; geopolitical events, natural disasters, acts of God and pandemics, including, but not limited to, the economic and operational disruptions and other effects of COVID-19; regulatory requirements and changes thereto; access to additional financing; and other risks and uncertainties indicated from time to time in filings with the SEC. Other factors include the possibility that the proposed transaction does not close, including due to the failure to receive required security holder approvals or the failure to satisfy other closing conditions. The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in SAMA’s most recent filings with the SEC and is contained in the Form S-4, including the proxy statement/prospectus. All subsequent written and oral forward-looking statements concerning SAMA, Clever Leaves or Holdco, the transactions described herein or other matters and attributable to SAMA, Clever Leaves, Holdco or any person acting on their behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Each of SAMA, Clever Leaves and Holdco expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Schultze Special Purpose Acquisition Corp.
George J. Schultze: [email protected]
Gary M. Julien: [email protected]
(914) 701-5260

Investor Relations
Raphael Gross
ICR
[email protected]
(203) 682-8253

Media Relations
KCSA Strategic Communications
McKenna Miller
[email protected]
(347) 487-6197


1 Requires SAMA common stock to trade at greater than $10.30 based on the volume weighted average stock price for the five trading days immediately prior to the redemption date in connection with the closing of the business combination.

BellRing Brands Announces Share Repurchase Authorization of $60 Million

ST. LOUIS, Nov. 12, 2020 (GLOBE NEWSWIRE) — BellRing Brands, Inc. (NYSE:BRBR) today announced its Board of Directors approved a $60 million share repurchase authorization over the next two years. Repurchases may be made from time to time in the open market, private purchases, through forward, derivative, alternative, accelerated repurchase or automatic purchase transactions, or otherwise. The authorization does not, however, obligate BellRing to acquire any particular amount of shares, and repurchases may be suspended or terminated at any time at BellRing’s discretion. The amount and timing of repurchases are subject to a variety of factors including liquidity, share price, market conditions and legal requirements.

Cautionary Statement on Forward-Looking Language

Forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, are made in this press release. These forward-looking statements are sometimes identified from the use of forward-looking words such as “believe,” “should,” “could,” “potential,” “continue,” “expect,” “project,” “estimate,” “predict,” “anticipate,” “aim,” “intend,” “plan,” “forecast,” “target,” “is likely,” “will,” “can,” “may” or “would” or the negative of these terms or similar expressions elsewhere in this press release. All forward-looking statements are subject to a number of important factors, risks, uncertainties and assumptions that could cause actual results to differ materially from those described in any forward-looking statements. These factors and risks include, but are not limited to, unanticipated developments that prevent, delay or negatively impact the repurchases, the rapidly changing situation related to the COVID-19 pandemic and other financial, operational and legal risks and uncertainties detailed from time to time in BellRing’s cautionary statements contained in its filings with the Securities and Exchange Commission. These forward-looking statements represent BellRing’s judgment as of the date of this press release. BellRing disclaims, however, any intent or obligation to update these forward-looking statements.

About
BellRing Brands
, Inc.

BellRing Brands, Inc. is a rapidly growing leader in the global convenient nutrition category. Its primary brands, Premier Protein®, Dymatize® and PowerBar®, appeal to a broad range of consumers across all major product forms, including ready-to-drink protein shakes, powders and nutrition bars, and are distributed across a diverse network of channels including club, food, drug, mass, eCommerce, specialty and convenience. BellRing’s commitment to consumers is to strive to make highly effective products that deliver best-in-class nutritionals and superior taste. For more information, visit www.bellring.com.

Contact:

Investor Relations
Jennifer Meyer
[email protected]
(314) 644-7665

Mesa Air Group Announces Fourth Quarter Fiscal Year 2020 Earnings Release and Conference Call Date

PHOENIX, Nov. 12, 2020 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) will release its fourth quarter earnings for fiscal year 2020 after the market closes on Wednesday, December 9. The company will also host a conference call to discuss the results on December 9 at 4:30 pm Eastern Time.

The call can be accessed by dialing 888-469-2054 and entering the passcode: PHOENIX (7463649).

There will also be a listen-only webcast on Mesa’s website (http://investor.mesa-air.com/events-and-presentations/events). A recorded version will be available on Mesa’s website approximately two hours after the call (http://investor.mesa-air.com).

About Mesa Air Group, Inc.

Headquartered in Phoenix, Arizona, Mesa Air Group, Inc. is the holding company of Mesa Airlines, a regional air carrier providing scheduled passenger service to 101 cities in 39 states, the District of Columbia, Canada and Mexico. As of October 31st, 2020, Mesa operated a fleet of 146 aircraft with approximately 342 daily departures and 3,200 employees. Mesa operates all of its flights as either American Eagle, United Express, or DHL Express flights pursuant to the terms of capacity purchase agreements entered into with American Airlines, Inc., United Airlines, Inc., and DHL.

Investor Relations
Brian Gillman
[email protected]

Media
Matthew Harris
[email protected]